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Abstract
Acinetobacter baumannii (Ab) is a common cause of community-acquired pneumonia (CAP) in chronic alcoholics in tropical
and sub-tropical climates and associated with a .50% mortality rate. Using a murine model of alcohol (EtOH)
administration, we demonstrated that EtOH enhances Ab-mediated pneumonia leading to systemic infection. Although
EtOH did not affect neutrophil recruitment to the lungs of treated mice, it decreased phagocytosis and killing of bacteria by
these leukocytes leading to increased microbial burden and severity of disease. Moreover, we determined that mice that
received EtOH prior to Ab infection were immunologically impaired, which was reflected in increased pulmonary
inflammation, sequential dissemination to the liver and kidneys, and decreased survival. Furthermore, immunosuppression
by EtOH was associated with deregulation of cytokine production in the organs of infected mice. This study establishes that
EtOH impairs immunity in vivo exacerbating Ab infection and disease progression. The ability of Ab to cause disease in
alcoholics warrants the study of its virulence mechanisms and host interactions.
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Introduction
Acinetobacter baumannii (Ab) is a Gram-negative bacterium that has
gained particular notoriety as one of the leading causes of
nosocomial infections, principally amongst immunocompromised
individuals [1]. Similarly, Ab is a primary agent for community-
acquired pneumonia (CAP), particularly in individuals with a
history of alcohol (EtOH) abuse who characteristically present a
fulminant clinical course with secondary bloodstream infection
and a .50% mortality rate in tropical and sub-tropical climates
[2]. Approximately 10% of alcoholics transiently carry this
bacterium in the nasopharynx which may act as the source of
infection [3]. To exacerbate the problem, Ab has an intrinsically
extraordinary ability to develop resistance to commonly used
antibiotics [4,5,6].
Excess EtOH consumption may lead to host’s innate and
acquired immune deficiency, causing increased susceptibility to
infections [7,8]. For instance, pneumonia mediated by Klebsiella or
Streptococcus pneumoniae augmented mortality in EtOH-treated
rodents [9,10]. Acute and chronic EtOH abuse alters the capacity
of monocytes to present antigens to T-cells [11] as well as
adversely modifying the levels of pro-inflammatory cytokines
produced by phagocytes [12]. Notably, natural killer cell
proliferation and activity are considerably reduced after EtOH
consumption [13]. Moreover, EtOH exposure elevates serum IgG
and IgA antibody levels, a clear indication of B-cell dysfunction
[14]. Furthermore, inflammatory mediators are negatively regu-
lated by immune cells following EtOH exposure [15].
Neutrophils circulate in the blood and are among the first cells
to arrive at the site of infection; thus, neutrophils play an
important role in early modulation of immune response to multi-
drug resistant Ab infection and tissue injury [16,17]. We have
recently shown the detrimental effects of EtOH on macrophages
in Ab infection [18]. However, there is lack of information about
EtOH effects on specific effector functions of neutrophils in Ab-
mediated pneumonia. In this study, we hypothesized that
physiological EtOH levels impair neutrophil antimicrobial re-
sponses enhancing Ab pathogenesis. We demonstrated that EtOH
damages neutrophil effector functions, an important factor that
might enhance the severity of community-acquired Ab pneumonia
in alcoholic patients resulting in high mortality.
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To our knowledge, this is the first study describing the role of
EtOH specifically on the setting of Ab infection using a mammal
experimental infection model. Furthermore, we explore the impact
of EtOH on neutrophils which play a critical role in host resistance
to respiratory Ab infection.
Materials and Methods
Bacteria
Ab 0057, a clinical isolate acquired from Mark D. Adams
(Cleveland, OH), was chosen for this study because it has been
sequenced and it is resistant to b-lactam antibiotics including
carbapenems but remain susceptible to tigecycline and colistin
[19,20]. The strain was collected from the bloodstream of a soldier
in 2004 at Walter Reed Army Medical Center, Washington DC.
The isolate was stored at 280uC in Tryptic Soy Broth (TSB; Difco
Laboratories, Detroit, MI) with 50% glycerol. Frozen stocks were
grown in TSB with rotary shaking at 150 rpm overnight at 37uC.
Optical density (OD) measurements were taken at 600 nm (Bio-
Tek, Winooski, VT) to monitor growth.
EtOH administration and infection
To investigate the effects of EtOH in Ab pneumonia, 100 ml of
25 mM of EtOH (correspond to 12% in human blood) (Sigma, St.
Louis, MO) or Phosphate-buffered saline (PBS; untreated controls)
was intraperitoneally (i.p.) injected to female C57BL/6 mice (age,
6–8 weeks; Charles Rivers, Wilmington, MA) daily for 7 days
before infection. Sub-lethal infections were induced by and
intranasal (i.n.) inoculation of 107 Ab cells after anesthetization
(ketamine [100 mg/Kg; Ketaset, Fort Dodge, IA]-xylazine
[20 mg/Kg; AnaSed, Shenandoah, IA] cocktail). For survival
studies, lethal infection was performed by i.n. inoculation with
56107 Ab cells. To monitor the impact of EtOH in mouse survival,
EtOH-injected and uninfected animals were used as additional
controls.
Ethics statement
All animal studies were conducted according to the experimen-
tal practices and standards approved by the Institutional Animal
Care and Use Committee (IACUC) at Long Island University
(Protocol #: 11–3). The IACUC at Long Island University
approved this study.
Colony forming units (CFU) determinations
At indicated time points (4, 24, 48, and 72 h) post-infection,
mouse tissues (lungs, liver, and kidney) were excised, perfused and
externally washed with sterile PBS, before being finally homog-
enized in PBS. Serial dilutions of homogenates were performed,
with 100 mL of each sample plated on TS agar (TSA; Difco) plates
and incubated at 37uC for 24 h. Subsequently, bacterial colonies
were counted and the results were normalized by tissue weights.
Cytokine and myeloperoxidase (MPO) determinations
Three mice per group were sacrificed at 4, 24, 48, and 72 h
post-infection. The organs of each mouse were excised, perfused
and externally washed with PBS, and finally homogenized in PBS
with protease inhibitors (Complete Mini; Roche, Ridgefield, CT).
Cell debris was removed from homogenates by centrifugation at
6,000 g for 10 min. Samples were stored at 280uC until tested.
(i) Cytokines. Supernatants were tested for IFN-c, TNF-a, IL-
1b, and IL-6 by ELISA (Becton Dickinson Biosciences, San
Diego, CA). The limits of detection were 31.3 pg/mL for
IFN-c and 15.6 pg/mL for TNF-a, IL-1b, and IL-6.
(ii) Myeloperoxidase (MPO). Supernatants were tested for
myeloperoxidase (MPO) by ELISA (Hycult Biotechnology,
The Netherlands). The limits of detection were 1 ng/mL for
MPO.
Histological processing
At indicated time-points (4, 24, 48, and 72 h) post-infection,
organs (lung, liver, and kidney) were excised and fixed in 4%
paraformaldehyde for 24 h. Tissues were processed, embedded in
paraffin, and 4 mm vertical sections were fixed to glass slides.
Tissue sections were stained with Hemotoxylin and Eosin (H&E),
Gram or MPO to assess morphology, bacteria, or neutrophil
infiltration, respectively. Microscopic examinations of tissues were
performed by light microscopy with an Axiovert 40 CFL inverted
microscope (Carl Zeiss, Thornwood, NY) and photographed with
an AxioCam MrC digital camera using the Zen 2011 digital
imaging software (Carl Zeiss).
Isolation of peripheral blood human neutrophils
Whole human blood was purchased from the Interstate Blood
Bank, Inc. (Memphis, TN). Upon arrival, blood cells were pelleted,
and erythrocytes removed by hypotonic lysis. Neutrophils were
separated from the remaining cells by centrifugation over
discontinuous Percoll gradients at 5006g for 30 min at 4uC,
consisting of 75% (vol/vol) Percoll in PBS. Neutrophils were
.95% viable as determined by Wright-Giemsa staining. Recov-
ered neutrophils (,98% as determined by fluorescence-activated
cell sorting (FACS) using Ly-6G as a marker) were cultured
(,30 min) in (37uC, 5% CO2) in RPMI 1640 (Cellgro, Manassas,
VA) supplemented with 10 mM HEPES (pH 7.4) and 10% fetal
calf serum (FCS) (Atlanta Biologicals, Lawrenceville, GA) prior to
use.
Neutrophil counts in blood
Seven days after EtOH administration neutrophil counts were
performed by differential leukocyte count in all experimental
animals using a Hema 3 Stat Pack kit (Fisher Scientific, Hanover
Park, IL) and light microscopy.
Chemotaxis assays
Chemotaxis was measured using a transwell chamber with
6.5 mm diameter polycarbonate filters (3 mm pore size; Corning,
Tewksbury, MA). Immediately after isolation, cells were incubated
in RPMI 1640 supplemented with FCS in the absence or presence
of EtOH (6.25 and 12.5 mM correspond to 3 and 6% of EtOH in
human blood, respectively) for 2 h. Then, cells were transferred to
RPMI 1640 supplemented with FCS, cultivated on filters and
allowed to migrate toward the chemo attractant fMLF (formyl-
methionyl-leucyl-phenylalanine, 1026 M; Sigma) or medium
alone at 37uC, 5% CO2. After 1 h, the filters were removed,
and the cells that migrated through the membrane were fixed,
stained and counted using light microscopy.
Phagocytosis assay
Phagocytosis was determined by FACS analysis. Human
neutrophils (106 cells) were incubated on 6 well plates with feeding
medium supplemented with EtOH (6.25 or 12.5 mM; Sigma), or
PBS for 2 h at 37uC and 5% CO2. FITC (Molecular Probes,
Grand Island, NY)-labeled Ab cells were incubated with 25%
human serum for 30 min to allow complement proteins to
opsonize Ab. Bacterial cells were washed and then 107 bacterial
cells were added to the 106 neutrophils for 2 h. Similarly,
extracellular bacteria were quenched with trypan blue to prevent
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interference with the assay. Samples were processed (10,000 events
per condition) on a LSRII flow cytometer (Becton Dickinson
Biosciences, San Diego, CA) and were analyzed using FlowJo
software.
Ab killing assay
Since EtOH reduces Ab phagocytosis by neutrophils, leukocytes
were first allowed to phagocytize Ab cells for 0.5 h to determine
the initial uptake. Each well containing interacting cells was gently
washed with feeding media and incubated with feeding media
supplemented with amikacin (200 mg/mL; to kill extracellular
bacteria) and either PBS or EtOH (6.25 and 12.5 mM) for 4 h.
Viable bacteria were released from neutrophils following 0.5 and
4 h of host-cell interaction by forcibly subjecting culture to a 27-
gauge needle passage 5–7 times for efficient lysis [21]. Four
microtiter wells per condition were used to ascertain CFU. For
each well, serial dilutions were plated in triplicates onto TSA
plates, which were incubated at 37uC for 24 h prior to CFU
tallying.
Nitric oxide determinations (NO)
Nitric oxide (NO) produced in supernatants by untreated or
EtOH-treated neutrophils was quantified after exposure to Ab
using a Griess method kit (Promega, Fitchburg, WI).
Luminol chemiluminescence assay
Reactive oxygen species (ROS) signals were made chemilumi-
nescent (CL) by luminol (1 mM). CL was monitored for 30 min
using the automatic luminescence analyzer SpectraMax L
(Molecular Devices, Sunnyvale, CA) at 37uC.
Statistical Analysis
Data were analyzed using Prism (GraphPad, LaJolla, CA).
Differences in survival rates were analyzed by the log-rank test
(Mantel-Cox). Analysis of cytokine, MPO, chemotaxis, CFU, NO,
and chemiluminescence data was done using analysis of variance
and adjusted by use of the Bonferroni correction. Analysis of
neutrophil count data was performed using student’s t-test. P
values of ,0.05 were considered significant.
Results
EtOH-treated mice display reduce survival in Ab infection
Administration of EtOH accelerated the death of Ab-infected
mice relative to control mice (P,0.01; Fig. 1). On day 3 post-
infection, 100% of EtOH-treated mice had died in comparison to
20% of the untreated mice. On average, EtOH-treated mice died
of Ab-mediated pneumonia 2 days post-infection compared to 9
days for untreated mice (Fig. 1). None of the animals in the EtOH-
uninfected group died (Fig. 1). Furthermore, similar to humans
who abuse EtOH, treated animals displayed marked stereotypic
behaviors such as loss of motor coordination and distress. These
behaviors were most apparent 5–10 min after EtOH injection and
continued for several hours.
EtOH exacerbates Ab-mediated pneumonia
In sub-lethally infected mice, pulmonary bacterial burden of
EtOH-treated animals was significantly higher than untreated
mice (P,0.05; Fig. 2A) 24 and 48 h after Ab infection. Histological
examination revealed that untreated-uninfected and EtOH-
treated-uninfected mice had minimal or no inflammation (data
not shown). After infection, untreated and EtOH-treated mice had
significant peribronchial inflammation and inflammatory cells
present within the alveoli (Fig. 2B). Gram staining showed gram
negative bacterial cells within the alveolar spaces of the lungs of
infected animal either untreated or EtOH-treated (Fig. 2B; insets;
upper panel). In summary, these studies demonstrated that EtOH
administration enhances disease progression by showing greater
pulmonary Ab burden compared to the untreated group as shown
in the CFU data. We measured pro-inflammatory cytokine
response (TNF-a, IFN-c, IL-1b, and IL-6) in the lungs of
untreated or EtOH-treated mice and uninfected or infected with
Ab at 4, 24, 48, and 72 h post-infection (Fig. 2C). The pulmonary
tissue of infected mice treated with EtOH and infected with Ab
contained significantly higher quantities of IL-1b (P,0.05) and
reduced levels of TNF-a (P,0.05) in contrast to other group
conditions. The untreated-Ab-infected group displayed significant-
ly lower levels of TNF-a (P,0.05) than untreated controls 24 h
post-infection. EtOH-treated animals showed the highest levels of
TNF-a (P,0.05) at 24–72 h. Similarly, EtOH-treated animals
exhibited the highest levels of IFN-c (P,0.05) at 48 and 72 h
whereas this cytokine was only significantly elevated in EtOH-
treated-Ab-infected mice 72 h post-infection. Lastly, untreated-Ab-
infected group evinced the highest levels of IL-6 production (24–
48 h; P,0.05), although EtOH-treated group showed a similar
increase in this cytokine at 72 h.
EtOH accelerates Ab dissemination from the lungs to
other organs
We investigated whether EtOH enhances Ab dissemination
from the lungs to other organs. Ab significantly disseminated from
the lungs of EtOH-treated mice to the liver in 24 h (P,0.05;
Fig. 3A) and to the kidneys in 72 h (P,0.05; Fig. 4A) after
intranasal infection. Histological analysis revealed hepatocellular
atrophy (Fig. 3B) and considerable presence of bacteria in the
livers of animals treated with EtOH (Fig. 3B; insets; upper panel).
We evaluated the levels of TNF-a, IFN-c, IL-1b, and IL-6 in the
hepatic tissue of untreated or EtOH-treated mice and uninfected
or infected with Ab at 24, 48, and 72 h post-infection (Fig. 3C).
The liver of infected animals treated with EtOH and infected with
Ab showed significantly lower levels of TNF-a (P,0.05), IFN-c
(P,0.05), and IL-1b (P,0.05) than those of the other experimen-
tal conditions. Untreated-Ab-infected and EtOH-treated animals
showed significant increase in TNF-a (P,0.05), IFN-c (P,0.05),
and IL-1b (P,0.05) levels compared to untreated controls. Also,
these three cytokines were highly elevated 24 h after Ab infection
Figure 1. Alcohol (EtOH) administration reduces survival in
C57BL/6 mice. Survival differences of EtOH and PBS-injected
(Untreated) C57BL/6 mice after infection with 56107Ab (n = 5 per
group). EtOH-treated and uninfected mice were use as additional
controls. Asterisks denote P-value significance (*P,0.01) calculated by
Log-Rank (Mantel-Cox) analysis. This experiment was performed twice
and similar results were obtained.
doi:10.1371/journal.pone.0095707.g001
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in untreated-Ab-infected and EtOH-treated groups but gradually
reduced at 48 and 72 h. Untreated-Ab-infected mice showed the
highest levels of IL-6 production (P,0.05). EtOH and Ab-infected
animals demonstrated lower IL-6 levels than EtOH-treated
animals (P,0.05) 24 h post-infection.
Kidneys excised from EtOH-treated animals presented nephro-
megaly with abnormally thickened basement membrane of the
glomeruli and cell proliferation (Fig. 4B). Additionally, high
bacterial burden was observed in EtOH-treated mice, mostly
accumulated in the glomeruli of the kidneys (Fig. 4B; insets; upper
panel). Untreated mice displayed uniform bacterial cell distribu-
tion throughout the cortex and medulla of this excretory organ
(Fig. 4B; inset; upper panel). We examined the levels of TNF-a,
IFN-c, IL-1b, and IL-6 in the kidneys of untreated or EtOH-
treated mice and uninfected or infected with Ab at 72 h post-
infection (Fig. 4C). The renal tissue of infected mice treated with
EtOH and infected with Ab contained significantly reduced levels
of TNF-a (P,0.05), IFN-c (P,0.05), and IL-1b (P,0.05)
compared to the other experimental conditions. Untreated-Ab-
infected and EtOH-treated animals exhibited significant increase
in TNF-a (P,0.05) and IL-1b (P,0.05) levels compared to
untreated controls. In addition, significant increases in IL-6
production (P,0.05) were observed in untreated-Ab-infected mice
compared to the other conditions.
EtOH enhances neutrophil infiltration
We examined whether EtOH administration affected the
number of circulating neutrophils in the blood of C57BL/6 mice
using differential leukocyte staining. Cell count analysis showed
that EtOH-treated animals had no difference in blood circulating
phagocytes when compared to controls (Fig. 5A).
MPO is highly produced by neutrophils, therefore, detection of
this enzyme is commonly used as a surrogate to quantify
neutrophil recruitment to different tissues. MPO yields hypo-
chlorous acid from hydrogen peroxide and chloride anion during
the neutrophil’s respiratory burst. Therefore, we assessed the effect
of EtOH on neutrophil recruitment in the lungs of C57BL/6 mice
by neutrophils. Mice treated with EtOH (P,0.001) or untreated
(P,0.001) resulted in significantly higher levels of MPO after Ab
infection than did untreated neutrophils (Fig. 5B). Similarly, we
identified neutrophil infiltration using immunohistochemistry
(IHC) by measuring the expression of MPO in pulmonary tissue.
Figure 2. EtOH exacerbates Ab-mediated pneumonia in vivo. (A) Bacterial burden (CFU; colony forming unit) in lungs excised from untreated
and EtOH-treated mice, infected with 107 Ab cells (n= 3 per group) 4, 24, 48, and 72 h post-infection. Solid and error bars denote the means and
standard deviations, respectively. Asterisks denote P-value significance (*P,0.05) calculated by analysis of variance (ANOVA) and adjusted by use of
the Bonferroni correction. This experiment was performed twice and similar results were obtained. (B) Histological analysis of lungs removed from
untreated-Ab-infected (Untr + Ab) and EtOH-treated-Ab-infected (EtOH + Ab) C57BL/6 mice 48 h post-infection. Representative low (10X; scale bar:
20 mm) and high (40X; scale bar: 10 mm) magnification H&E-stained sections of the lungs are shown with Gram staining insets (upper panel; Scale
bars: 10 mm) showing the gram-negative Ab. (C) Cytokines levels (TNF-a, IFN-c, IL-1b, and IL-6; pg/mL) in the lungs of C57BL/6 mice. Solid and error
bars denote the means and standard deviations, respectively. Symbols denote P-value significance (P,0.05) calculated by ANOVA and adjusted by
use of the Bonferroni correction. *, Q, ‘ indicate higher levels than untreated, untr + Ab, EtOH groups, respectively. #, p, x indicate lower levels than
untreated, untr + Ab, EtOH groups, respectively. These experiments were performed twice and similar results were obtained.
doi:10.1371/journal.pone.0095707.g002
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Tissue sections from EtOH murine lungs infected with Ab
exhibited early (4 h) and massive neutrophil infiltrations when
compared to lungs excised from untreated-infected animals
(Fig. 5C). Additionally, uninfected lungs demonstrated minimal
neutrophil infiltration (data not shown). To confirm the IHC
findings, EtOH was tested for its ability to promote human
neutrophil chemotaxis in vitro. EtOH exposure (6.25 mM;
P,0.001 and 12.5 mM; P,0.001) significantly stimulated higher
leukocyte migration than untreated or fMLF-treated controls
(Fig. 5D).
EtOH reduces neutrophils phagocytosis and killing of Ab
We analyzed the effects of physiological EtOH on Ab
phagocytosis and killing by neutrophils using FACS analysis.
EtOH reduced phagocytosis of Ab by neutrophils, compared with
the control (Fig. 6A). Our results showed a 17.3 and 73.5%
phagocytosis inhibition in cells treated with 6.25 and 12.5 mM
EtOH, respectively, when compared to control cells. We examined
whether EtOH interferes with neutrophil-mediated killing of Ab
cells. EtOH significantly reduced bacterial killing by human
neutrophils (P,0.05) (Fig. 6B). Consequently, we investigated the
impact of EtOH on extracellular NO production by these
leukocytes after co-incubation with Ab. Our results indicate that
NO levels were significantly reduced in the supernatants of EtOH-
treated cells (6.25 mM; P,0.05 and 12.5 mM; P,0.001) when
compared to controls (Fig. 6C). Finally, neutrophils mostly kill
bacteria via NADPH oxidase-derived ROS. Hence, we evaluated
the impact of EtOH on neutrophils’ oxidative burst by measuring
luminol chemiluminescence intensity. Increased concentration of
EtOH significantly decreased ROS production compared to
untreated-Ab neutrophils (P,0.05; 15 to 60 min). Minimal
production of ROS was observed in untreated and unstimulated
control cells.
Discussion
EtOH abuse has been previously shown to predispose the host
to CAP, particularly to multi-drug resistant Ab resulting in
significant illness and mortality [2]. In this study, we demonstrated
that EtOH administration had a profound effect on survival in
mice i.n. challenged with Ab. The increased mortality in EtOH-
treated mice was attributable to the inability of immune cells to
clear infection. We observed a significant increase in bacterial
burden in the lungs of EtOH-treated animals, compared to
Figure 3. EtOH accelerates Ab dissemination from the lungs to the liver after 24 h of infection. (A) Bacterial burden (CFU) in liver (24, 48,
and 72 h post-infection) excised from untreated and EtOH-treated mice, infected with 107 Ab 0057 strain (n=3 per group). Solid and error bars
denote the means and standard deviations, respectively. Asterisks denote P-value significance (*P,0.01) calculated by ANOVA and adjusted by use of
the Bonferroni correction. This experiment was performed twice and similar results were obtained. (B) Histological analysis of liver removed from
untreated- and EtOH-treated-Ab-infected C57BL/6 mice. Representative low (10X; scale bar: 20 mm) and high (40X; scale bar: 10 mm) magnification
H&E-stained sections of the liver are shown with Gram staining insets (upper panel; Scale bars: 10 mm) showing the gram-negative Ab (72 h post-
infection). (C) Cytokines levels (TNF-a, IFN-c, IL-1b, and IL-6; pg/mL) in the liver of C57BL/6 mice. Solid and error bars denote the means and standard
deviations, respectively. Symbols denote P-value significance (P,0.05) calculated by ANOVA and adjusted by use of the Bonferroni correction. *, Q, ‘
indicate higher levels than untreated, untr + Ab, EtOH groups, respectively. #, p, x indicate lower levels than untreated, untr + Ab, EtOH groups,
respectively. These experiments were performed twice and similar results were obtained.
doi:10.1371/journal.pone.0095707.g003
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controls. After infection and in contrast to untreated animals,
EtOH-treated mice displayed high inflammation and number of
inflammatory cells present within the alveoli suggesting that
increased Ab burden and reduced animal survival were not
attributable to a diminished recruitment of immune cells to the
lungs, but to decreased cellular microbicidal capacity. In this
regard, high levels of IL-1b present in the pulmonary tissue of
EtOH-treated mice suggest that this cytokine compensates the late
production of TNF-a and IFN-c. In contrast, untreated-Ab-
infected mice displayed early high levels of TNF-a followed by a
time-dependent reduction of this cytokine and elevated levels of
IL-1b and IL-6 which may explain reduced bacterial burden in
these animals. Another contributing factor to the inability of
treated mice to reduce bacterial numbers is that EtOH changes
pulmonary surfactant production which may result in a lessening
antibacterial activity [22].
MPO IHC demonstrated that EtOH-treated animal experi-
enced earlier and higher recruitment of neutrophils to the lungs
post-infection than the untreated-Ab-infected group. To confirm
the IHC results, quantitative analysis exhibited a considerable
time-dependent increased and sustained MPO production in
pulmonary tissue of EtOH-treated animals. Perhaps, EtOH
stimulates early and uncontrolled massive recruitment of neutro-
phils to the infection site increasing the probability of tissue
damage by activated leukocytes. This observation is also supported
by dysregulated levels of pro-inflammatory cytokines found in lung
homogenates of EtOH-treated mice. For instance, neutrophil
apoptosis might be impaired extending the presence of these
phagocytic cells in lung tissue which might be detrimental for the
host’s tissue architecture [23,24]. Consistent with previous studies,
our findings indicated that EtOH administration did not reduce
neutrophil infiltration to the infection site [25], which might
suggest that this substance of abuse impairs the ability of
phagocytic cells to engulf and kill Ab within the lungs [26,27],
resulting in early dissemination of infection to the bloodstream and
other organs. For example, human neutrophils treated with
physiological levels of EtOH showed increased chemotaxis in vitro
and decreased Ab phagocytosis and killing. Similarly, we have
recently shown that EtOH-mediated phagocytosis dysfunction
may be associated with reduced expression of GTPase-RhoA, a
key regulator of the actin polymerization signaling cascade using a
murine J774.16 macrophage-like cell line [18].
After phagocytosis, bacteria are rapidly exposed to the
microbicidal armamentarium conferred by neutrophils, which
Figure 4. EtOH enhances Ab dissemination from the lungs to the kidney 72 h post-infection. (A) Bacterial burden (CFU) in kidneys (24, 48,
and 72 h post-infection) excised from untreated and EtOH-treated mice, infected with 107 Ab 0057 strain (n=3 per group). Solid and error bars
denote the means and standard deviations, respectively. Asterisks denote P-value significance (*P,0.01) calculated by ANOVA and adjusted by use of
the Bonferroni correction. This experiment was performed twice and similar results were obtained. (B) Histological analysis of kidneys removed from
untreated- and EtOH-treated-Ab-infected C57BL/6 mice. Representative low (10X; scale bar: 20 mm) and high (40X; scale bar: 10 mm) magnification
H&E-stained sections of the kidneys are shown with Gram staining insets (upper panel; Scale bars: 10 mm) showing the gram-negative Ab (72 h post-
infection). (C) Cytokines levels (TNF-a, IFN-c, IL-1b, and IL-6; pg/mL) in the kidneys of C57BL/6 mice. Solid and error bars denote the means and
standard deviations, respectively. Symbols denote P-value significance (P,0.05) calculated by ANOVA and adjusted by use of the Bonferroni
correction. *, Q, ‘ indicate higher levels than untreated, untr + Ab, EtOH groups, respectively. #, p, x indicate lower levels than untreated, untr + Ab,
EtOH groups, respectively. These experiments were performed twice and similar results were obtained.
doi:10.1371/journal.pone.0095707.g004
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consist of toxic reactive species, such as NO, and lysosomal
hydrolases. Our data show that NO generation is significantly
decreased in neutrophils that are exposed to EtOH. This
phenomenon might be explained by reduction in TNF-a levels.
Impaired production of NO and ROS might create an ideal
environment for microbial survival, facilitating intracellular
replication and dysregulation of the phagolysosomal milieu. For
instance, EtOH reduced NO production by alveolar macrophages
after challenge with Mycobacterium tuberculosis [28]. Recent work in
our laboratory demonstrated that inducible NO synthase expres-
sion is reduced after macrophage-like cells were exposed to EtOH
[18].
Liver damage is common in EtOH users, often leading to
hepatitis, cirrhosis, and fatty liver. The accumulation of EtOH in
the liver may be responsible for the hepatocellular atrophy we
observed in EtOH-treated animals. One of the potential mech-
anisms by which EtOH can cause exacerbation of Ab infection is,
in part, linked to the deleterious interaction of EtOH and bacterial
lipopolysaccharide (LPS) on the immune response [29]. Thus,
EtOH induced immunosuppression may be promoting this gram
negative organism’s dissemination and replication within hepatic
tissue. Surprisingly, we observed reduced levels of TNF-a, which
have been previously implicated with cell death and liver damage
in alcoholics when overproduced by Kupffer cells [30,31,32]. Our
findings provide fundamental insights into how EtOH may play an
important role in Ab infection-related morbidity and mortality in a
vertebrate model of infection.
Chronic alcohol consumption can cause kidney dysfunction,
mainly in conjunction with established liver disease. Excised
kidneys from EtOH-treated mice exhibited higher Ab burden and
swelling than controls at 72 h post-infection. Bacterial distribution
in the renal tissue was also different with Ab accumulation in the
glomeruli of EtOH-treated mice as opposed to uniform dispersed
bacteria throughout the organ observed in the control animals.
This result suggests that EtOH predispose alcoholics to urinary
tract infections and consequent kidney failure which may result in
death [33,34]. This clinical scenario is complicated by the multi-
drug resistance capacity of Ab and reduced pro-inflammatory
cytokine production, increasing the host’s susceptibility to an
Figure 5. EtOH administration and Ab infection increases pulmonary neutrophil infiltration. (A) Number of neutrophils per field in blood
of untreated or EtOH-treated mice. Each black circle or red square represents the numbers of phagocytes per individual field. Dashed lines and error
bars denote average of ten counts and standard deviations, respectively. P-value significance (P,0.05) was calculated using student’s t-test analysis.
(B) Pulmonary myeloperoxidase (MPO) levels. After EtOH administration and Ab infection, homogenates of extracted lungs from C57BL/6 mice were
prepared and the supernatants were analyzed for MPO levels. * and # indicates increased MPO levels compared to untreated and untreated-Ab-
infected (Untr + Ab) groups, respectively. (C) Histological analysis of lungs removed from untreated-Ab infected and EtOH-treated-Ab-infected C57BL/
6 mice. Representative MPO-stained sections show neutrophil infiltration (brown staining). Scale bars: 10 mm. (D) Human neutrophil migration after
exposure of uninfected cells to the chemoattractant fMLF. Peripheral neutrophils were isolated from human blood and treated with PBS (untreated)
or EtOH (6.25 or 12.5 mM). Neutrophils unexposed to fMLF were used as controls. For (B) and (D), solid and error bars denote the means and
standard deviations, respectively. Asterisks denote P-value significance (*, #P,0.001) calculated by ANOVA and adjusted by use of the Bonferroni
correction. These experiments were performed twice and similar results were obtained.
doi:10.1371/journal.pone.0095707.g005
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adverse prognosis. Similarly, kidney enlargement in alcoholics is of
clinical significance.
Although Cheung et al., have previously shown that the
differential count for the neutrophils in young and mature rats
treated with alcohol is lower than in untreated animals [35]. In
humans, various abnormalities in circulating neutrophils also have
been described with alcohol consumption, ranging from an
increase in the number of these cells in the peripheral blood to
neutropenia in those with the most severe form of infection or
severe underlying hepatic disease [36]. We found that EtOH-
treated animals had no differences in blood circulating neutrophils
when compared to untreated controls further supporting the
notion that Ab infection could not be controlled in EtOH-treated
animals due to a reduction of the antimicrobial effector functions
of these leukocytes.
Previous studies have shown that EtOH exposure may increase
Ab virulence. For instance, EtOH promotes secretion of the outer
membrane protein OmpA, which is important in Ab biofilm
formation and induces epithelial cell apoptosis [37,38,39].
Similarly, co-culture of Ab with the baker’s yeast Saccharomyces
cerevisiae promoted bacterial growth, primarily due to fungal-
mediated EtOH production [40]. Perhaps, EtOH provides Ab with
the capacity to tolerate salt stress, making Ab an extremely
successful opportunistic pathogen for persons abusing alcohol who
copiously sweat due to increased body heat. Ab genomic and
proteomic analyses revealed that EtOH regulates genes responsi-
ble for stress responses, drug resistance, iron transport, and biofilm
formation [41,42]. Furthermore, EtOH enhances Ab pathogenesis
in invertebrate models of infection [42,43,44].
The majority of CAP-Ab infections occur in individuals with
underlying comorbidities, who reside in tropical and subtropical
climates [45]. For instance, Australians aborigines in the Northern
Territory are overrepresented relative to the general population in
rates of CAP caused by Ab [46]. This disparity has been attributed
to the interaction of both climate and a high prevalence of
comorbidities in the indigenous Australian population including
alcoholism, diabetes mellitus, chronic obstructive pulmonary
disease and cigarette smoking [46,47]. Although it is not clear
whether immune cell dysfunction directly contributes to CAP Ab
infection in humans, our study revealed that EtOH administration
is positively associated with the progression of this infection in an
animal model. Moreover, alcohol consumption has been previ-
ously correlated with impaired immune responses including
alveolar macrophages dysfunction in phagocytosis, killing of
bacteria, and cytokine secretion [46].
Figure 6. EtOH reduces human neutrophil phagocytosis, nitric oxide production, and killing of Ab. Neutrophils were untreated or
exposed to EtOH for 2 h followed by incubation with Ab. (A) Phagocytosis of FITC-labeled Ab by human neutrophils was determined using
Fluorescent Activated Cell Sorting (FACS) analysis. Representative histograms are shown. (B) Killing of Ab by neutrophils was determined using
colony-forming units (CFU) analysis. Solid and error bars denote means and standard deviations, respectively. Symbols denote P-value significance
(P,0.05) calculated by ANOVA and adjusted by use of the Bonferroni correction. * and # indicate higher CFU numbers than untreated and 6.25 mM
EtOH groups, respectively. (C) Nitric oxide (NO) production was quantified using the Griess method after untreated or EtOH-treated neutrophils were
co-incubated with Ab. Untreated and uninfected neutrophils were also used as controls. Solid and error bars denote means and standard deviations,
respectively. Symbols denote P-value significance (P,0.05) calculated by ANOVA and adjusted by use of the Bonferroni correction. *, #, & indicate
lower levels than untreated, 6.25 and 12.5 mM EtOH groups, respectively. (D) Oxidative burst was quantified for 60 min using luminol
chemiluminescence after untreated or EtOH-treated neutrophils were co-incubated with Ab. Untreated and uninfected neutrophils were also used as
controls. Symbols and error bars denote means and standard deviations, respectively. P-value significance (P,0.05; discussed in result section) was
calculated by ANOVA and adjusted by use of the Bonferroni correction at each time point. For (A)–(D), experiments were performed twice and similar
results were obtained.
doi:10.1371/journal.pone.0095707.g006
Alcohol Enhances Acinetobacter baumannii Pneumonia
PLOS ONE | www.plosone.org 8 April 2014 | Volume 9 | Issue 4 | e95707
It is important to mention that CAP-Ab is almost never detected
in countries outside the tropics despite the fact that alcohol abuse is
common in many countries around the world. It is possible that
tropical regions are favorable and optimal for the growth of Ab in
the environment. For instance, Ab is a very resilient microbe
resistant to high temperature ($47uC) and desiccation [48].
Nevertheless, correlating climate and infection is out of the scope
of this study, a very interesting question to pursue in future studies.
In conclusion, this is the first report that experimentally
demonstrates that EtOH intensifies Ab-associated pneumonia
and disease progression in vivo by deregulating neutrophil
antimicrobial functions. The synthesis of these findings, including
recent advances in Ab virulence studies, should raise awareness on
the negative impact of EtOH abuse in alcoholics, specifically in
prevalent regions. The ability of Ab to cause disease in alcoholics
underscores how the study of its virulence mechanisms and host
interactions is necessary.
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